$INBX
Inhibrx Biosciences, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$92.76
▼-0.64%-$0.600
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateInhibrx Biosciences, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is INBX down today? It is at $92.76 (-0.64%), and our scanner flagged it 57 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment INBX spikes, and full due diligence on INBX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $INBX 57 times in the last 30 days. Create a free account to track $INBX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on INBX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INBX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing4Insider trade (Form 4)Sep 28, 2026 · 10 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Lappe Mark Officer | Bought (open market) | +5K 0.03% of company | added 0.5% | 960K | $445K at $98.88 | Sep 28, 26 |
Lappe Mark Officer | Bought (open market) | +6K 0.04% of company | added 0.8% | 736K | $544K at $98.87 | Sep 25, 26 |
Kayyem Jon Faiz Director | Bought (open market) | +5K 0.03% of company | added 0.5% | 1.07M | $500K at $100.00 | Sep 23, 26 |
Kayyem Jon Faiz Director | Bought (open market) | +5K 0.03% of company | added 0.5% | 1.07M | $500K at $100.00 | Sep 16, 26 |
Manhard Kimberly Director | Sold (automatic/other) | -500 | sold 6.3% | 8K | $53K at $105.05 | Sep 15, 26 |
Manhard Kimberly Director | Sold (automatic/other) | -500 | sold 5.9% | 8K | $55K at $110.26 | Sep 14, 26 |
Manhard Kimberly Director | Sold (automatic/other) | -500 | sold 5.6% | 9K | $56K at $111.78 | Sep 11, 26 |
Manhard Kimberly Director | Sold (automatic/other) | -500 | sold 5.3% | 9K | $58K at $115.80 | Sep 9, 26 |
Lappe Mark Officer | Bought (open market) | +25K 0.2% of company | added 2.7% | 950K | $2.5M at $99.29 | Sep 8, 26 |
Forsyth Douglas Director | Bought (open market) | +3K 0.02% of company | added 1.1% | 227K | $287K at $114.65 | Sep 8, 26 |
Kayyem Jon Faiz Director | Bought (open market) | +5K 0.03% of company | added 0.5% | 1.06M | $568K at $113.52 | Sep 8, 26 |
Manhard Kimberly Director | Sold (automatic/other) | -500 | sold 5.0% | 10K | $58K at $115.14 | Sep 8, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on INBX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INBX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
INBX last traded at $92.76, down 0.64% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Inhibrx Biosciences, Inc. Common Stock (INBX) is next expected to report earnings on Friday, November 13, 2026, about 36 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The INBX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged INBX 57 times in the last 30 days.
INBX (Inhibrx Biosciences, Inc. Common Stock) trades on XNAS, with a market cap of about $1.37B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge INBX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$INBX discussion
Sign in to ask a question or join the discussion.